THE increase of debilitating disorders, like asthma, may have sent shock waves amongst the human population worldwide, but has resulted in a windfall for the pharmaceutical industries the world over. The year past - 1995 - saw drug sales soaring to record levels: markets in the top nine countries including us, Japan, Germany, France, Italy, Spain, the Netherlands and Belgium posted a growth of eight per cent as compared to' five per cent in 1994 and one per cent in 1993. Records released by ims International, a drugs industry market research organisation, recently put the us drug market as the fastest growing, followed by the UK and Japan. Giving the industry a boost were drugs like Prozac, an anti-depressant, manufactured by Eli Lilly of the us, and Zantac, an ulcer drug manufactured by UK's Glaxo Wellcome.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.